Skip to main content

Stocks fluctuated on Monday after Donald Trump offered some detail about his incoming budget, including a massive bump in defense spending. 

The S&P 500, the Dow Jones Industrial Average, and the Nasdaq traded flat to slightly higher.

Trump on Monday said he had proposed an "historic increase" in defense spending, which would be offset with cuts elsewhere. Non-defense spending will be cut by $54 billion with a budget blueprint to be offered in early March, according to an official from the Office of Management and Budget. Most agencies will see spending cuts, according to the official.

Trump also said he plans to spend "big" on infrastructure with a statement on his plans set for Tuesday.

Markets have been characterized by small moves and a lack of volatility in recent sessions as investors seek out the next catalyst for direction, argued James "Rev Shark" Deporre on RealMoney, our premium site for investors. 

"While the uptrend since Nov. 7 has been amazingly strong, what is more notable about the action is the lack of volatility," Deporre wrote in his column on Monday. "The DJIA hasn't had a move of over 1% in a day for 53 days now. That hasn't occurred in over 10 years. The S&P 500 has set records for lack of volatility also, but the upside progress has been steady as a rock."

The Dow extended its record-breaking streak on Friday with a nail-biting end to the trading day. The blue-chip index turned positive with just seconds to go after spending most of the day sharply lower. The Dow began its long stretch of records 11 sessions earlier on optimism over Trump's forthcoming tax plan, reforms the president again touted on Friday. 

Markets also hope Trump will provide further details on his tax plans and other policy positions in a speech to a joint session of Congress on Tuesday. White House Press Secretary Sean Spicer said, "The address will particularly focus on public safety including defense, increased border security, taking care of veterans, and then economic opportunity including education, job training, health care reform, jobs and tax and regulatory reform."

"We expect they will be only modestly disappointed by a general restatement of Trump's priorities," said TD Securities analysts. "Comments suggesting close cooperation with Congressional Republicans would be positive for markets; emphasis on populist measures or a strident, antagonistic tone would be negative." 

TheStreet Recommends

Pending home sales in January fell to their lowest level in a year as lower inventory failed to meet high demand. The number of sales wherein a contract has been signed but a deal not yet closed fell by 2.8% in January. Economists had expected sales to rise by 1.1%. 

Durable goods orders rose in January thanks to higher demand for airplanes. Orders for long-lasted U.S. goods increased 1.8% last month. Durable orders, excluding transportation, declined by 0.2%, while core capital goods orders slid 0.4%. 

Sotheby's (BID) - Get Sotheby's Report  rose 14% after besting quarterly earnings and revenue estimates. The auction house earned an adjusted $1.35 a share, higher than consensus of $1.17. Revenue fell to $308.7 million from $335.8 million a year earlier, though exceeded estimates of $269 million. 

Shutterstock (SSTK) - Get Shutterstock, Inc. Report sank 16.7% on Monday after missing profit and sales estimates in its recent quarter. The stock image database earned an adjusted 42 cents a share, 3 cents shy of consensus. Revenue of $130.2 million came in under expectations of $135.3 million. Shutterstock also guided for full-year sales no higher than $560 million, below a target of $578.2 million. 

Apple (AAPL) - Get Apple Inc. Report inched higher on Monday after billionaire investor Warren Buffett raised his stake in Apple to 133 million shares worth around $17 billion, nearly double his previous position. Buffett told  CNBC that he likes the "incredible stickiness" of Apple's consumer products. 

La Jolla Pharmaceuticals (LJPC) - Get La Jolla Pharmaceutical Company Report  roared 77% higher on Monday after announcing that significantly more shock patients with critically low blood pressure responded to treatment with its experimental drug LJPC-501 compared to placebo. The results achieved the main goal of a phase III clinical trial. The drugmaker will submit a marketing application to the U.S. Food and Drug Administration in the second half of this year. 

WATCH MORE: What You Need to Know About La Jolla's Shock-Treatment Drug

Tesla (TSLA) - Get Tesla Inc Report was downgraded to sell from neutral at Goldman Sachs. The Model 3 launch will likely be delayed, leading to higher free cash flow burn, Goldman said.

Under Armour (UAA) - Get Under Armour, Inc. Class A Report was downgraded to reduce from neutral at Nomura. Analysts said the valuation is unattractive as growth is maturing. Urban Outfitters (URBN) - Get Urban Outfitters, Inc. Report was downgraded to sell at MKM Partners. The firm warned of deteriorating sales and margins at Anthropologie.

The last batch of economic data with Barack Obama as president will come out in the next few weeks with the coming sessions looking particularly busy. The second estimate of fourth-quarter GDP, international trade for January, Chicago PMI and consumer confidence for February is set for Tuesday; personal income and outlays for January, the ISM Manufacturing Index for February, and the Beige Book are due for release on Wednesday; and the ISM Non-Manufacturing Index for February is scheduled for Friday.